期刊文献+

NLK以激酶非依赖的方式抑制Smad4的转录活性

NLK inhibits the transcription activity of Smad4 independent of its kinase activity
原文传递
导出
摘要 目的验证Nemo样激酶(NLK)与Smad4之间的相互作用并探讨NLK对Smad4功能的影响。方法应用免疫共沉淀和谷胱甘肽硫基转移酶(GST)沉降技术检测NLK与Smad4之间相互作用,GST沉降技术确定Smad4与NLK相互作用的结构域,荧光素酶报告基因实验检测NLK及NLK激酶活性突变体-NLK(KM)对Smad4转录活性的影响,体内磷酸化实验检测NLK对Smad4磷酸化的影响。结果免疫共沉淀和GST沉降的结果显示,NLK与Smad4在体内和体外存在相互作用。GST沉降的结果显示Smad4通过MH2结构域与NLK结合。荧光素酶报告基因实验的结果显示,NLK和NLK(KM)均可抑制Smad4的转录活性,且抑制程度相同。体内磷酸化的结果显示,NLK不能磷酸化Smad4。结论 NLK与Smad4相互作用,以激酶非依赖的方式抑制Smad4的转录活性,NLK抑制Smad4的分子机制有待进一步探讨。 Objective To confirm the interaction betweem NLK and Smad 4 and to explore the effect of NLK on the function of Smad4.Methods Co-immunoprecipitation and GST Pull-down were used to detect the interaction between NLK and Smad4.GST Pull-down was used to map the domain through which Smad 4 interacts with NLK.Luciferase reporter gene assay was used to study the effect of NLK and NLK (KM), the NLK mutant lacking kinase activity , on the transcrip-tion activity of Smad4.In vivo phosphorylation assay was used to detect whether NLK phosphorylated Smad 4 or not.Results The data of Co-immunoprecipitation and GST Pull-down showed that NLK interacted with Smad 4 in vivo and in vitro.The result of GST Pull-down showed that Smad4 interacted with NLK via MH2 domain.The results of luciferase reporter gene assay indicated that both NLK and NLK (KM) inhibited the transcription activity of Smad4.The result of in vivo phospho-rylation assay showed that NLK could not phosphorylate Smad 4 in vivo.Conclusion NLK interacts with Smad4 and inhibits the transcription activity of Smad 4 independent of the kinase activity of NLK .The mechanism through which NLK negatively regulates the transcription of Smad 4 requires further research .
出处 《军事医学》 CAS CSCD 北大核心 2014年第3期189-192,202,共5页 Military Medical Sciences
基金 国家自然科学基金重点资助项目(NO.30630035)
关键词 蛋白激酶 SMAD4 转录活性 NLK NLK protein kinase transcription activity
  • 相关文献

参考文献20

  • 1Massague J, Blain SW, Lo RS. TGFbeta signaling in growth con-trol, cancer, and heritable disorders [J]. Cell, 2000, 103(2) : 295 - 309.
  • 2Massague J. TGFbeta in Cancer [J]. Cell, 2008, 134(2) : 215 - 230.
  • 3Yang J, Li X, Al-Lamki RS, et al. Smad-dependent and smad- independent induction of idl by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo [J]. Circ Res, 2010, 107(2) : 252 -262.
  • 4Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling[ J]. Nature, 2003, 425 (6958) : 577 -584.
  • 5Feng XH, Derynck R, Specificity and versatility in TGF-beta sig- naling through Smads[J]. Annu Rev Cell Dev Biol, 2005, 21: 659 - 693.
  • 6Lagna G, Hata A, Hemmati-Brivanlou A, et al. Partnership be- tween DPC4 and SMAD proteins in TGF-beta signalling pathways [J]. Nature, 1996, 383(6603): 832 -836.
  • 7Lin X, Liang M, Liang YY, et al. SUMO-1/Ubc9 promotes nu- clear accumulation and metabolic stability of tumor suppressor Smad4 [J]. J Biol Chem, 2003, 278(33) : 31043 -31048.
  • 8Liang M, Melchior F, Feng XH, et al. Regulation of Smad4 su- moylation and transforming growth factor-beta signaling by protein inhibitor of activated STATI [ J ]. J Biol Chem, 2004, 279 (22) : 22857 - 22865.
  • 9Long J, Wang G, He D, et al. Repression of Smad4 transcrip- tional activity by SUMO modification[ J ]. Biochem J, 2004, 379 (Pt 1): 23-29.
  • 10Wan M, Cao X, Wu Y, et al. Jabl antagonizes TGF-beta signa- ling by inducing Smad4 degradation [ J ]. EMBO Rep, 2002, 3 (2) : 171 - 176.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部